Mesirow Financial Investment Management, Inc. Esperion Therapeutics, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.84 Billion
- Q2 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 20,000 shares of ESPR stock, worth $57,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$57,600
Previous $28,000
32.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ESPR
# of Institutions
183Shares Held
108MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$40.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$33.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$29.8 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$28.7 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$19.2 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $192M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...